Empowering frontline doctors heroes with AI

Biocogniv leverages state-of-the-art AI to deliver actionable insights to frontline providers, reducing time-to-answer, misdiagnoses, and costs.

Introducing AI-COVID™

In response to the global pandemic, Biocogniv developed the world's first AI model for predicting the likelihood of COVID-19 infection using only routine blood tests.

0.91 AUC in a large, multi-center study

With data from over 60 US hospitals and nearly 200,000 patients, Biocogniv has carried out one of the most robust real world data studies in COVID-19.

New platforms for a new generation of medical tools

AI has the potential to disrupt virtually every facet of medical care. To power this transformation, Biocogniv has developed RemoteDx™ and ROCfinder™, two revolutionary platforms that serve as the foundation of our work.

From the frontlines

“Our collaboration with Biocogniv has led to a powerful demonstration of the utility of AI in medicine, showing how one can predict COVID infection by analyzing blood tests we routinely order.”

Vic Tapson, MD FCCP FRCP

Associate Director
Pulmonary and Critical Care Division
Cedars-Sinai Medical Center, CA

“Biocogniv's platform is a key enabler for laboratories to deliver value above and beyond commodity test results. From machine learning to automated interpretations, I firmly believe this trend to be a key part of the future of laboratory medicine.”

Peter McCaffrey, MD FCAP

Director, Lab Information Services
Director, Pathology Informatics
UTMB, TX

“AI-COVID could be extremely useful for hospitals because it only uses commonly collected blood tests to give meaningful information on a patient's likelihood of testing positive with molecular tests.”

Tim Plante, MD MHS

Department of Medicine
Larner College of Medicine at the University of Vermont, VT
Press coverage